Nele Festjens and Nico Callewaert of VIB and Ghent University have improved the efficacy of the vaccine for tuberculosis. The new vaccine affords - as already proven in mice - better protection against the disease. The development of a new tuberculosis vaccine is a priority in the fight against the disease which claims the lives of 1.7 million people each year. The current vaccine provides only partial protection. Nico Callewaert: "Our vaccine is more effective because it is more quickly recognized by the immune system of the vaccinated person...
No comments:
Post a Comment